“Bimekizumab speed of response in patients with moderate to severe plaque psoriasis: Results from four phase 3/3b trials (BE VIVID, BE READY, BE SURE, and BE RADIANT)” (2022) SKIN The Journal of Cutaneous Medicine, 6(6), p. s69. doi:10.25251/skin.6.supp.69.